CSS
DXCM icon

Cubist Systematic Strategies’s DexCom DXCM Stock Holding History

Cubist Systematic Strategies’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$31.9M Buy
+474,151
New +$37.5M 0.15% 142
2025
Q2 		– Sell
-332,755
Closed -$26.1M – 3097
2025
Q1 		$22.7M Buy
332,755
+287,392
+634% +$23.5M 0.14% 159
2024
Q4 		$3.53M Buy
+45,363
New +$3.36M 0.02% 1031
2024
Q2 		– Sell
-32,558
Closed -$4.12M – 3237
2024
Q1 		$4.52M Sell
32,558
-103,424
-76% -$13M 0.03% 1024
2023
Q4 		$16.9M Sell
135,982
-4,422
-3% -$452K 0.11% 211
2023
Q3 		$13.1M Sell
140,404
-25,211
-15% -$2.84M 0.1% 261
2023
Q2 		$21.3M Sell
165,615
-18,159
-10% -$2.2M 0.14% 110
2023
Q1 		$21.4M Sell
183,774
-40,452
-18% -$4.53M 0.13% 140
2022
Q4 		$25.4M Buy
224,226
+121,669
+119% +$13.4M 0.15% 84
2022
Q3 		$8.26M Sell
102,557
-117,645
-53% -$9.96M 0.05% 621
2022
Q2 		$16.4M Buy
220,202
+198,030
+893% +$18.1M 0.1% 201
2022
Q1 		$2.84M Sell
22,172
-148,508
-87% -$16.2M 0.02% 1204
2021
Q4 		$22.9M Buy
170,680
+157,096
+1,156% +$22.6M 0.22% 35
2021
Q3 		$1.86M Sell
13,584
-68,596
-83% -$8.65M 0.02% 1072
2021
Q2 		$8.77M Buy
82,180
+81,144
+7,832% +$7.79M 0.1% 268
2021
Q1 		$93K Sell
1,036
-53,160
-98% -$4.99M ﹤0.01% 2657
2020
Q4 		$5.01M Buy
54,196
+14,964
+38% +$1.34M 0.07% 442
2020
Q3 		$4.04M Sell
39,232
-139,240
-78% -$14.5M 0.06% 510
2020
Q2 		$18.1M Sell
178,472
-29,040
-14% -$2.6M 0.31% 30
2020
Q1 		$14M Sell
207,512
-144,736
-41% -$9.01M 0.38% 32
2019
Q4 		$19.3M Buy
352,248
+307,164
+681% +$14.6M 0.35% 17
2019
Q3 		$1.68M Sell
45,084
-7,376
-14% -$287K 0.03% 706
2019
Q2 		$1.97M Sell
52,460
-4,056
-7% -$127K 0.04% 698
2019
Q1 		$1.68M Sell
56,516
-55,204
-49% -$1.94M 0.05% 512
2018
Q4 		$3.35M Buy
111,720
+22,976
+26% +$729K 0.16% 120
2018
Q3 		$3.17M Buy
88,744
+68,824
+346% +$2.13M 0.17% 105
2018
Q2 		$473K Buy
19,920
+15,920
+398% +$338K 0.02% 820
2018
Q1 		$74K Sell
4,000
-12,996
-76% -$192K ﹤0.01% 1636
2017
Q4 		$244K Buy
16,996
+7,456
+78% +$96.9K 0.01% 1397
2017
Q3 		$117K Sell
9,540
-41,232
-81% -$729K 0.01% 1596
2017
Q2 		$928K Buy
50,772
+45,856
+933% +$847K 0.06% 457
2017
Q1 		$104K Sell
4,916
-266,748
-98% -$5.21M 0.01% 1388
2016
Q4 		$4.05M Sell
271,664
-60,808
-18% -$1.08M 0.32% 35
2016
Q3 		$7.29M Buy
332,472
+324,916
+4,300% +$7.23M 0.47% 13
2016
Q2 		$150K Sell
7,556
-171,624
-96% -$2.92M 0.01% 1422
2016
Q1 		$3.04M Buy
179,180
+57,556
+47% +$961K 0.17% 117
2015
Q4 		$2.49M Buy
121,624
+24,544
+25% +$511K 0.15% 160
2015
Q3 		$2.08M Buy
97,080
+53,148
+121% +$1.19M 0.11% 237
2015
Q2 		$878K Buy
+43,932
New +$772K 0.04% 649
2015
Q1 		– Sell
-122,988
Closed -$1.69M – 1931
2014
Q4 		$1.69M Buy
+122,988
New +$1.51M 0.09% 309
2014
Q3 		– Sell
-66,144
Closed -$656K – 1763
2014
Q2 		$656K Buy
+66,144
New +$586K 0.04% 632

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Cubist Systematic Strategies's DXCM Position: Q3 2025 in Review

Cubist Systematic Strategies opened a new position in DexCom (DXCM) in Q3 2025: 474,151 shares worth $31.9M. The stake represents 0.15% of the portfolio and ranks #142 among its holdings. This is a return to the name: Cubist Systematic Strategies previously reported a position in DXCM as recently as Q1 2025.

Cubist Systematic Strategies first reported a position in DXCM in Q2 2014 and has held it in 41 quarters since. 910 funds tracked by Wall St. Rank hold DXCM as of Q3 2025.

  • Cubist Systematic Strategies held 474,151 shares of DexCom worth $31.9M as of Q3 2025.
  • DexCom was a new Cubist Systematic Strategies position in Q3 2025.
  • DexCom made up 0.15% of Cubist Systematic Strategies's portfolio in Q3 2025, its #142 holding.
  • Cubist Systematic Strategies first reported a position in DexCom in Q2 2014 and has held it in 41 quarters since.
  • 910 funds tracked by Wall St. Rank held DexCom as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.